City

Rock Hill (1)

Condition

Chronic Obstructive Pulmonary Disease, COPD (1)

Low Peak Inspiratory Flow Rate (PIFR) (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Mylan Inc. (1)

Collaborator

Theravance Biopharma (1)

Intervention

placebo for revefenacin (1)

placebo for spiriva handihaler® (1)

revefenacin (1)

spiriva handihaler® (1)

Study Documents

Intervention Type

combination product (1)

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

low peak inspiratory flow rate (pifr)

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

COPD, COPD, Low Peak Inspiratory Flow Rate (PIFR) Trial in Rock Hill (Revefenacin, Spiriva Handihaler®, Placebo for Revefenacin)

Completed

Chronic Obstructive Pulmonary Disease, COPD
Low Peak Inspiratory Flow Rate (PIFR)

Revefenacin
+3 more

Rock Hill, South Carolina

Clinical Research of Rock Hill

Feb 22, 2022